Keywords: AstraZeneca, Forest, ceftaroline, skin infection treatment

AstraZeneca buys rights to co-develop Forest’s ceftaroline

Article | 12 August 2009

Print This

UK drug major AstraZeneca and the USA’s Forest Laboratories have entered into a definitive collaboration agreement to co-develop and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in